Related Experiment Videos
Myocardial infarction management with peripheral streptokinase
Annals of Emergency Medicine
|November 1, 1984
Summary
Intravenous (IV) streptokinase administration for acute myocardial infarction (MI) shows higher reperfusion rates and fewer complications than intracoronary methods. This approach offers comparable left ventricular function improvement and easier administration for myocardial salvage.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Early management of myocardial infarction (MI) is evolving with new treatment modalities.
- Intracoronary fibrinolytic agents are increasingly accepted for acute MI treatment.
Purpose of the Study:
- To compare the efficacy and safety of peripheral intravenous (IV) versus direct intracoronary streptokinase administration in acute MI patients.
- To evaluate clinical, electrocardiographic, and hemodynamic outcomes of both treatment strategies.
Main Methods:
- A pilot protocol involving 30 acute MI patients consecutively assigned to receive either intracoronary (n=15) or IV (n=15) streptokinase (1.5 million units over 30 minutes).
- Evaluation included clinical symptoms, ECG, hemodynamic studies, angiography, and radionuclide ventriculography.
Main Results:
- Both IV and intracoronary streptokinase showed comparable beneficial results.
- IV streptokinase therapy was initiated 1.5 hours earlier and resulted in a higher incidence of reperfusion.
- Comparable improvement in left ventricular function was observed in both groups.
Conclusions:
- IV streptokinase therapy may be preferable for acute MI due to higher reperfusion rates, fewer complications, and simpler administration.
- This method offers a valuable option for institutions lacking invasive cardiac procedures.
- Cooperation between emergency and cardiology departments is encouraged for optimal myocardial salvage.